ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions
View by Date
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Daily Immunosuppression to Combat Compliance in Adolescent Kidney Transplant

    A. L. Brubaker1, A. McGrath2, L. Maestretti2, A. Chaudhuri2, P. C. Grimm2, A. Gallo1

  • DAMPs and NLRP3 Inflammasome Response in Fatty Liver Grafts Preservation in Different Preservation Solutions

    R. G. Bardallo1, R. G. Teixeira-Silva2, A. Panisello-Rosello3, E. Folch-Puy3, J. Rosello Catafau4, T. Carbonell5

  • Daratumumab for Desensitization and Antibody Mediated Rejection Treatment in Highly-HLA Sensitized Patients

    S. Jordan, R. Vescio, N. Ammerman, M. Toyoda, S. Ge, M. Chu, J. Hou, E. Huang, A. Peng, S. Sethi, R. Najjar, K. Lim, J. Kobashigawa, J. Patel, E. Kransdorf, A. Vo

  • DCD vs DBD Liver Transplantation: Equivalent Charges and Similar Survival- An Effective Expansion of the Donor Pool

    N. Singh, K. Helfrich, M. Alebrahim, C. Akateh, K. Mumtaz, A. Logan, A. Schenk, S. Black, E. Elkhammas, K. Washburn, A. El-Hinnawi

  • dd-cfDNA as a Risk Factor for Initiating De-Novo Donor Specific Antibodies in Heart Transplantation

    E. DePasquale1, J. Kobashigawa2, S. Pinney3, K. Khush4

  • De Novo Dosing and Trough Attainment Trends of Extended-Release Tacrolimus in the Absence of Dose Adjustments

    M. J. Moritz1, D. R. Stevens2, U. Meier-Kriesche2, T. A. Horwedel2

  • De Novo Dosing of LCP-Tacrolimus Using Conservative Weight-Based Strategy Resulted in Supratherapeutic Trough Levels in Majority of Patients

    J. Dann, J. Geyston, M. Wassimi, K. Brayman, A. Doyle

  • De Novo DSA in the Setting of Stable Renal Allograft Function Does Not Impair Long-Term Graft Survival

    R. Knight1, D. T. Nguyen2, E. A. Graviss2, O. Gaber1

  • De Novo Malignancy after Liver Transplantation for Alcoholic Cirrhosis: Incidence and Outcomes

    M. M. Pascale, E. Nure, G. Bianco, F. Frongillo, S. Agnes

  • De Novo NAFLD Post-Liver Transplant is Defined by Altered Lipid Metabolism and Mitochondrial Dysfunction

    M. Bhat1, E. Pasini1, M. Angeli1, J. Allard2, A. Humar1

  • De Novo Use of Envarsus (LCPT) in African American and Elderly Kidney Transplant Recipients: An Early Single Center Experience

    N. Wilson1, R. Leek1, R. Forbes2, D. Shaffer2, S. Rega3, I. Feurer3, B. Concepcion4, A. Langone4

  • Deceased Donor Body Temperature is Associated with Delayed Graft Function in Kidney Transplant Recipients

    J. Mancinelli1, N. Mahmud2, L. Krumeich1, M. Harhay3, P. P. Reese4, D. Goldberg5, P. Abt6

  • Deceased Donor Families and Authorization for Research: Differences among Ethnic Groups

    M. Ortigosa-Goggins, J. J. Gaynor, E. Shipman, L. Preczewski, G. Guerra

  • Deceased Donors in Kidney Paired Donation

    J. D. Kalbfleisch1, W. Wang1, M. A. Rees2, A. B. Leichtman3, P. X. Song1, V. Ashby1, T. Shearon1

  • Decision Support Needs for African American Kidney Transplant Candidates and Social Support Networks

    W. T. McKinney1, A. Hart1, S. Kurschner2, M. Bruin3, J. Zulema-Woodward4, M. Partin2, R. Patzer5

  • Decision-Making, Motivations and the Donation Experience among HLA-Identical Living Kidney Donors at UCLA – A Qualitative Study

    E. L. Wood1, S. George2, N. Kogut1, E. Lum3, J. Veale1

  • Declining Inpatient Mortality for Patients with Human Immunodeficiency Virus (HIV) and Cirrhosis: A Temporal Analysis of the Nationwide Inpatient Sample

    A. Kaplan, C. Lucero, B. Fortune, A. Jesudian, R. S. Brown Jr, R. Rosenblatt

  • Decoding the Troubled Allograft: Proteinuria within the 1st Post-Transplant Year Associates with and Risk Stratifies Inflamed Renal Transplants

    A. Cherukuri, R. Mehta, A. Tevar, R. Munjal, K. Kalra, C. Puttarajappa, P. Sood, C. Wu, S. Hariharan

  • Decreased Anti-Tumor Activity of Liver-Resident NK Cells via IL-33 Associated with Portal Hypertension after Living Donor Liver Transplantation

    Y. Imaoka, M. Ohira, K. Sato, H. Ohdan

  • Deep Learning for Living Donor Surgery: AI Recognition of Surgical Video to Develop Navigation Systems for Laparoscopic Nephrectomy

    M. Nishihara1, K. Iwadoh2, M. Noriyuki1, I. Koyama2, I. Nakajima2, M. Tonsho1

  • Deficiencies in Family Planning Counseling and Practices in Kidney Transplant Patients

    J. Ritchie1, D. Seidman2, Y. Srisengfa2, E. Perito2, D. Adey2, M. Sarkar2

  • Defining the Psychological Profile of Living Organ Donors Using Personality Assessment Inventory

    W. T. Branagan1, S. Huett1, M. Grafals2, W. E. Jackson3, E. A. Pomfret4

  • Delayed Graft Function Adversely Affects Long-Term Survival for Kidney Recipients after Non-Renal Solid-Organ Transplantation

    J. A. Reyes, C. Blanton, M. Eerhart, G. Leverson, P. Chlebeck, Y. Yankol, L. Fernandez

  • Delayed Graft Function in the Recipients of Simultaneous Liver and Kidney Transplant: A Single-Center Experience

    F. Aziz, B. Muth, N. Garg, M. Mohamed, D. Mandelbrot, J. Mezrich, A. Djamali, S. Parajuli

  • Delayed Graft Function Predicts High Risk of Allograft Loss Following Living and Deceased Donor Pediatric Kidney Transplantation

    M. MacConmara1, J. Gattineni1, D. Desai1, J. Parekh2, P. Vagefi1, C. S. Hwang1

  • Delayed Introduction of Mammalian Inhibitors of Rapamycin (mTOR) Post Kidney Transplantation Might Avoid the Chronic Nephrotoxicity of Calcineurin Inhibitors. Herein We Are Reporting an Eight-Years Single Center Experience of mTOR-Based Immunosuppression Regimen in Comparison with Cyclosporin-Based Regimen

    W. A. Hassan1, H. M. Tawfik2

  • Delayed Kidney Graft Function in Simultaneous Pancreas-Kidney Transplant Recipients is Associated with Pancreas Allograft Failure

    S. Parajuli, B. Muth, B. C. Astor, R. R. Redfield, D. Mandelbrot, J. Odorico, A. Djamali, D. Kaufman

  • Delayed Kidney Transplant (KT) up to 2 Days in Combined Liver-Kidney Transplantation (CLKT) Offers Similar Renal Function as KT Alone: Comparison Analysis with Mate Kidneys

    B. Ekser1, E. Taber-Hight2, P. Mihaylov1, C. A. Kubal1, R. S. Mangus1, J. A. Fridell1, A. J. Lutz1, O. Adebiyi3, T. E. Taber3, A. Sharfuddin3, M. S. Yaqub3, D. P. Mishler3, M. D. Anderson3, J. A. Powelson1, W. C. Goggins1

  • Deleterious Effect of Intravenous Steroids on Bone Mineral Density in Patients Treated for Borderline Rejection of the Renal Allograft

    S. T. Suliman, D. O. Hodge, M. B. Prendergast

  • Depletional Induction Improves Kidney Graft and Patient Survival in Recipients with a Previous Liver Transplant in the United States

    S. M. Riad1, N. Lim1, S. Jackson2, A. Matas3, J. Lake1

  • Depletional Profiles of Human and Rhesus Specific Anti-Thymocyte Globulins in Rhesus Macaques

    B. I. Shaw1, R. Schmitz1, D. M. Magnani2, F. Leopardi1, A. D. Kirk1

  • Depression Screening Protocol in Post Transplant Clinic. Implementing the A3 Scientific Method for Improving Patient Safety

    W. M. Potts, A. Anthony, K. Brayman, A. Doyle

  • DEPTOR Expression within CD4+Foxp3+ T Regulatory Cells is Crucial for B Cell Activation Responses and Immunoregulation

    J. Wedel1, M. Maslyar1, S. Kong1, M. Laplante2, D. M. Briscoe1

  • Desensitization Combining Costimulation Blockade with Proteasome Inhibition in Highly Sensitized Transplant Candidates

    S. Restaino1, D. Jennings2, G. Serban3, E. Vasilescu3, G. Sayer1, N. Uriel1, K. Takeda4, Y. Naka4, M. Farr1, M. V. Habal1

  • Desensitization for Deceased Donor Transplantation: Testing a New Paradigm in the Nonhuman Primate

    Z. W. Fitch, R. Schmitz, P. M. Schroder, M. Manook, A. Y. Choi, J. Yoon, J. Kwun, S. J. Knechtle

  • Determinants of Cardiovascular Benefit Observed in a Population with a Functioning Renal Transplant versus Patients Undergoing Chronic Dialysis

    J. Sleiman, C. Castellaro, G. Laham, M. Schiavone, M. Biain, L. Brukman, G. Soler Pujol, C. Diaz

  • Determinants of Kidney Transplant Candidates’ Willingness to Accept Deceased Donor Organ Intervention Research: A Conjoint Analysis

    E. Gordon1, P. Reese2, J. Lee1, L. Krishnamurthi1, R. Veatch3, R. Knight4, P. T. Conway4, S. Dunn5, P. Abt2

  • Determination of Programmed Cell Death Protein 1 (PD1) by Flow Cytometry, a Possible Follow-Up Tool in Renal Transplantation of High Immune Risk

    M. Carmona-Escamilla1, M. Fonseca2, J. Prieto Chávez3, L. Arriaga4, F. Oviendo5, S. , Hernández-Mendoza SA2, J. Alberu6, G. Queipo2

  • Determining Prognostic Factors of Longitudinal Estimated Glomerular Filtration Rate Curves Using Machine Learning Techniques

    P. Bernhardt, J. Han, M. Kormaksson, J. Pascual, S. Berger, S. Chadban, C. Legendre, R. Oberbauer, F. Oppenheimer, C. Sommerer, A. Gawai, H. Tedesco

  • Detrimental Effects of Donor Brain Death on Tolerance Induction May be Eliminated by Delaying Mixed Chimerism in Non-Human Primates

    J. M. O1, W. Sommer2, K. Ahrens1, P. Patel1, D. Becerra1, J. Morrissette1, T. Costa1, K. Pruner1, J. Paster1, A. Bean1, A. Dehnadi1, I. Hanekamp1, I. Rosales1, R. Smith1, R. Colvin1, G. Benichou1, J. Allan3, T. Kawai1, J. Madsen4

  • Developing a Patient Specific Search of Heart Transplant Programs: Feedback from Heart Transplant Candidates and Recipients

    W. T. McKinney1, M. J. Bruin2, C. R. Schaffhausen1, S. Chu2, J. Synder3, C. M. Martin4, T. Alexy4, B. L. Kasiske5, A. K. Israni1

  • Development and Cell Surface Testing of a Novel Nanofiber Technology for Targeted Delivery of Therapeutic Regulatory T Cells

    J. M. Mathew1, S. Lee2, Y. Sambandam1, L. A. Fraser2, T. D. Clemons2, A. Kolberg2, J. He1, L. C. Palmer2, M. T. McClendon2, Z. J. Zhang1, J. R. Leventhal1, S. I. Stupp2, L. Gallon1

  • Development and Characterization of Decellularized Whole Human Livers for Increasing Donor Pool

    A. Acun, R. Oganesyan, B. E. Uygun

  • Development and Impact of DSA after Lung Transplant

    M. Henderson1, G. Morris2, C. Burt1, A. Feist1, J. Kozuch1, E. Schonhoft3, G. Yung3, T. Floreth3, K. Afshar3, E. Golts4, M. Mariski1

  • Development of a New Kidney Paired Donation (KPD) Program: Starting a Domino Chain with a Deceased Donor

    L. Furian1, C. Di Bella2, C. Silvestre2, F. Neri2, F. Tuci2, M. Cardillo3, E. Cozzi4, P. Rigotti1

  • Development of a Novel Multidrug Combination to Defat Steatotic Rat Liver via Normothermic Machine Perfusion

    M. Xu1, F. Zhou1, O. Ahmed1, G. Upadhya1, J. Jia1, C. Lee1, J. Xing1, L. Ye1, S. Shim1, Z. Zhang1, K. Byrnes2, B. Wong1, J. Kim1, Y. Lin1, W. Chapman1

  • Development of a Split Liver Machine Perfusion Protocol to Provide Comparative Controls in Assessing Therapeutic Interventions

    J. A. Attard1, L. Wallace1, Y. Boteon1, V. Ronca1, D. Osei-Bordom1, Y. Oo1, H. Mergental2, D. Mirza2, S. Afford1

  • Development of a Transplant Financial Aid Tool Kit

    C. Rogers1, K. Minghella1, K. Sullivan1, J. Ryan1, E. Keegan-Pits1, M. Cote1, S. Shao1, K. Joyal1, R. Youn2, N. Elias1

  • Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction

    R. Hod Dvorai1, R. Lee2, P. Muluhngwi2, M. Raijmakers3, A. Shetty2, A. Tambur2, M. Ison2

  • Development of DSA Class II is Associated with Immunosuppressive Monotherapy and Increased Risk for Graft Fibrosis, Chronic Rejection and Graft Loss

    M. Sterneck1, B. Sultani1, A. Ozga2, S. Weidemann3, J. Hermann4, E. Grabhorn5, U. Herden6, L. Fischer6

  • Development of Novel Multivariable Logistic Regression Model for Predicting Graft Failure within 2 Weeks and 4 Weeks after Liver Transplantation Using Post-Transplantation Laboratory Values

    J. Kwon, S. Kim, G. Choi, J. Joh, J. Park, J. Rhu, K. Kim, O. Lee, M. Lim, E. Jeong, J. Yang

  • Development of Recommendations for Liver Transplant Anesthesia Teams Using a Modified Delphi Process

    C. Crouch, A. Hendrickse, S. Mandell

  • Development of Self-Limited Low-Level BK Viremia/Viruria Suggests Ideal Immunosuppression to Suppress T-Cell and Antibody-Mediated Rejection and to Preserve Kidney Allograft Function

    B. Näf, T. Müller, R. Wüthrich, T. Schachtner

  • Diabetes Burnout: An Under-Recognized Risk-Factor in Post-Transplant Care Management

    N. Pilch, P. Baliga, V. Rao, V. Rohan, K. Foster, H. Perkins, N. Patel, D. Dubay, D. Taber

  • Diagnostic Method of Acute Kidney Rejection after Transplantation Using Metabolome Analysis via a Liquid Biopsy Approach

    H. Iwamoto

  • Did the 250 Nautical Mile Circle Work? Geographic Disparities in Lung Transplantation Before and after the Policy Change

    M. Kosztowski1, Y. Yu2, A. Massie2, D. L. Segev2, S. E. Gentry2

  • Differences in Alemtuzumab Dosing Does Not Affect Early Kidney Transplant Outcomes

    A. Pressley, R. Stratta, J. Rogers, A. Farney, G. Orlando, W. Doares, A. Reeves-Daniel, C. Jay

  • Differences in Immunosuppressive Therapy among Liver Retransplantation Recipients in a National Cohort

    A. K. Mezochow, P. L. Abt, T. Bittermann

  • Different Prognostic Impact of Liver Transplantation According to Liver Disease Etiologies

    S. Nagai, T. Kitajima, S. Yeddula, D. Moonka, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud

  • Diligent Prospective BK Virus (BKV) Monitoring and Management Post Kidney Transplant to Mitigate Risk of BK Nephropathy and Rejection: A Single Center Experience

    A. Dao1, M. Madhrira2, S. Allam2

  • Direct Acting Anti-Viral Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic Donors to Hepatitis C Negative Kideney Transplant Recipients

    G. Gupta, I. Yakubu, D. Kumar, I. Moinuddin, L. Kamal, A. King, C. Bhati, A. Sharma, A. Cotterell, A. Khan, M. Levy, R. Sterling

  • Discontinuation Rates in Multicenter Trials – Are They Driven by Attitudes or Facts?

    B. Nashan1, F. Braun2, D. Dragun3, I. A. Hauser3, P. Schemmer2, H. J. Schlitt2, C. Sommerer3, B. Suwelack3, C. Schiedel4, I. Kroeger4, F. Thaiss3

  • Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection

    R. El Fekih1, A. Alghamdi1, J. Hurley2, C. Coticchia2, J. Choi1, H. Allos1, S. Eskandari1, S. Bentink2, V. Tadigotla2, L. Riella1, J. Markmann3, K. Safa3, R. Formica4, J. Skog2, J. Azzi1

  • Discrepant Subtyping of Blood Type A2 Living Kidney Donors in Paired Kidney Exchange

    L. Warnke1, R. R. Redfield1, K. M. Miller1, M. Cooper2, G. Roll3, C. Freise3, B. Lee3, V. Chipman3, A. Thomas4, D. Leeser5, M. Ronin6, G. Hil6, A. D. Waterman7, D. Mandelbrot1

  • Dissecting Humoral Alloimmune Sensitization: A Dynamic Interplay of Different Cellular Compartments

    A. Torija, A. Favà, E. Crespo, M. Jarque, M. Meneghini, N. Bolaños, J. Grinyo, O. Bestard

  • Distance and Community Characteristics are Associated with Waitlist Mortality Prior to Lung Transplantation

    H. Hoy, W. Gannon, S. Rega, J. Karp, E. Lambright, E. Gillaspie, M. Bacchetta, I. Feurer

  • Distribution of High-Urgency Listing and Regional Variation before and after Implementation of the 2018 US Heart Allocation Policy

    T. Cascino1, M. Skeans2, V. Patel1, M. Colvin1

  • Divergent Molecular Pathways Underlie the Evolution of Allograft Fibrosis in Two Mouse Models of Chronic Lung Allograft Dysfunction

    T. Watanabe, J. Allen, K. Boonstra, Z. Guan, K. Bei, S. Keshavjee, J. Yeung, T. Martinu, S. Juvet

  • Do Higher Remuzzi Scores Make Good Kidneys Bad? Examining Histologic Criteria within the Framework of Single Kidney Transplantation

    V. Fleetwood1, C. Kensinger2, C. Papageorge1, D. Aufhauser1, P. Pasha1, G. Leverson3, B. Welch1, D. Foley1

  • Do the Characteristics of Donor Specific Antibody Truly Predict Severity of Cardiac Allograft Vasculopathy Late after Transplantation?

    K. Nishihara, J. Patel, M. Kittleson, D. Chang, E. Kransdorf, D. Geft, A. Shen, L. Czer, F. Esmailian, J. A. Kobashigawa

  • Does Antibiotic Prophylaxis at Ureteral Stent Removal Reduce Urinary Tract Infections in Kidney Transplant Recipients?

    M. Tarokh1, B. Frainey2, M. Fascelli3, D. Goldfarb1, A. Wee3, M. Eltemamy3

  • Does Choice of Inferior Vena Cava Reconstruction Technique Have an Impact on the Short and Long Term Postoperative Renal Function in Liver Transplant Recipient?

    S. Chartier-Plante1, S. Asrani2, J. Bayer2, H. Fernandez2, A. Gupta2, E. Martinez2, G. J. Mckenna2, N. Onaca2, N. Onaca2, R. M. Ruiz2, G. Saracino2, A. Wall2, G. Testa2

  • Does Donor Terminal, Admission or Best Estimate Glomerular Filtration Rate Predicts Kidney Transplantation Outcomes

    G. Irish1, T. Coates2, P. Clayton2

  • Does Hope for a Better Future or Fear of Death Motivate Kidney Patients More? A Decisional Balance Exploration of Motivation to Pursue Living Donor Kidney Transplant

    H. Rafiqzad1, A. Wasim1, A. Rezaeishahreza1, J. Lam1, A. Li1, T. Mahiuddin1, A. D. Waterman2, M. Novak1, I. Mucsi1

  • Does Pretransplant C-Peptide Influence Outcomes Following Simultaneous Pancreas-Kidney Transplantation: A Case-Control Study

    V. Gurram, K. Gurung, J. Rogers, A. Farney, G. Orlando, C. Jay, A. Reeves-Daniel, A. Mena-Gutierrez, N. Sakhovskaya, W. Doares, S. Kaczmorski, M. Gautreaux, R. Stratta

  • Does Recovery Rate of Renal Plasma Flow after Kidney Transplantation Differ in the Choice of Renal Arterial Anastomotic Site?

    T. Yonekura, K. Shinoda, K. Nishikawa, M. Maeda, H. Oguchi, Y. Hidaka, T. Mizutani, K. Sakurabayashi, M. Muramatsu, T. Kawamura, K. Sakai, S. Shishido

  • Does the Choice of Renal Arterial Anastomotic Methods in Kidney Allografts with Multiple Renal Arteries Affect the Recovery Rate of Renal Plasma Flow after Kidney Transplantation?

    K. Nishikawa, K. Shinoda, T. Yonekura, M. Maeda, H. Oguchi, Y. Hidaka, M. Muramatsu, T. Kawamura, Y. Hamasaki, K. Sakai, S. Shishido

  • Does the Distance from the Transplant Center Impact Kidney Transplant (KT) DGF, CIT and Outcomes?

    M. Laftavi1, O. Pankewycz2, R. Shahbazov1, A. Almonte1, B. Gallay2, J. Leggat2, R. Hod Dvorai1, C. Hubbell1, S. Narsipur2

  • Does the New Heart Transplantation Allocation System Improve Access to Transplantation for Restrictive and Hypertrophic Cardiomyopathy Patients? A UNOS Database Analysis

    R. Y. Loyaga-Rendon1, D. R. Fermin1, M. Jani1, R. L. Grayburn1, S. Lee1, M. G. Dickinson1, M. Gonzalez1, N. K. Shrestha2, T. Boeve3, S. Jovinge2, M. Leacche3

  • Does the Type of Procurement and Preservation Influence the Results after Non-Heart-Beating Kidney Transplant from a Maastricht III Donor?

    V. López, C. Casas, J. Alonso, M. Cabello, D. Hernández

  • Does Transplantation of Hepatitis C Infected Kidneys Into Uninfected Recipients Cause Hepatitis C-Associated Kidney Injury?

    R. H. Naik, S. Shawar, R. C. Forbes, H. Schaefer, D. Shaffer, M. Rossi, V. Imperio, B. P. Concepcion, M. Kapp

  • Domestic U.S. Transplant Tourism: Analysis of U.S. Citizens Who Travel to Another State for Transplant

    R. S. Mangus, M. F. Mount

  • Dominant Negative Polymorphisms in TNFRSF13B are Associated with Poor Transplant Outcome

    M. G. de Mattos-Barbosa1, E. T. Luning Prak2, E. Farkash3, J. L. Platt4, M. Cascalho4

  • Domino Transplantation – Expanding the Liver Donor Pool to the Pediatric Recipient

    U. Ekong1, N. Yazigi1, K. Khan1, S. Kaufman1, K. Chapman2, E. Leon2, N. Ah Mew2, A. Kroemer1, R. Girlanda1, J. Hawksworth1, C. Matsumoto1, T. Fishbein1

  • Donor and Recipient Sex Affect Transplant Outcomes in an Age-Specific Fashion

    R. Maenosono1, Y. Nian1, J. Iske1, Y. Liu1, H. Azuma2, E. Milford3, S. G. Tullius1

  • Donor Derived Cell Free DNA (dd-cfDNA) and Gene Expression Signatures of Antibody-Mediated Rejection (ABMR) May Improve Accuracy of ABMR Diagnosis (Dx)

    H. Zhang1, C. C. Nast2, E. Huang3, N. Ammerman3, A. A. Vo3, S. C. Jordan3, M. Toyoda1

  • Donor Derived Parvovirus B19 Infection

    W. Peng, J. Lv, J. Wu, J. Chen

  • Donor Derived Transmissions 2018: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

    M. Michaels1, B. Plucinski2, E. Ward2, L. Strasfeld1, M. Malinis1, C. Ho1, L. Danziger-Isakov1, J. Bucio1, G. Berry1, M. Rana1, C. Marboe1, S. Aslam1, R. Razonable1, S. Pouch1, G. F. Marklin1, J. Levitsky1, D. Levine1, A. Agarwal1, R. LaHoz1

  • Donor Intervention and Recipient Treatment with Recombinant Human C1 Inhibitor Prevents Delayed Graft Function in a Non-Human Primate Model of Kidney Transplantation

    J. A. Reyes1, C. Blanton1, M. Eerhart1, P. Chlebeck1, M. Springer1, Y. Ponstein2, E. van Amersfoort2, J. Torrealba3, Y. Yankol1, A. D'Allessandro1, L. Fernandez1

  • Donor Kidney Perfusion Fluid Extracellular Vesicles as Markers of Graft Function

    A. K. Rutman, S. Negi, N. Saberi, J. Tchervenkov, S. Paraskevas

  • Donor Lung Travel Distance and Time

    C. Lehr1, M. Skeans2, M. Valapour1, E. Lease3

  • Donor Mesenchymal Stem Cells in Combination with Co-Stimulation Blockade Prolong Allograft Survival

    A. J. Matar, B. P. Lovasik, S. C. Kim, C. A. Breeden, D. A. Faber, D. V. Mathews, J. Regenold, A. Ghosh, A. Stephenson, W. H. Kitchens, A. B. Adams

  • Donor-Derived Cell-Free DNA (dd-cfDNA) Levels in Stable Pediatric Kidney Transplant Recipients

    M. Waide, J. Carmody, I. G. Restaino

  • Donor-Derived Cell-Free DNA Combined with Histology Improves Prediction of eGFR Decline in Kidney Transplant Recipients over Histology Alone

    M. Gillespie, M. Haas, K. Lim, A. Vo, A. Peng, R. Najjar, S. Sethi, S. Jordan, E. Huang

  • Donor-Derived Cell-Free DNA for Detection of Cell-Mediated Rejection in Low Risk Kidney Transplant Patients

    S. Anand, L. Dong, M. Fife, J. Krong, S. Dow, D. Morris, T. Srinivas

  • Donor-Derived Cell-Free DNA is Not Influenced by Steroid Dosing in Heart Transplant Recipients

    J. Teuteberg1, S. Krim2, M. Shullo3, S. Jimenez1, H. Eisen4

  • Donor-Derived Cell-Free DNA Kinetics in Stable Kidney Transplant Patients Are Related to Donor/Recipient Variables

    S. Anand, L. Dong, S. Dow, M. Fife, J. Krong, D. Morris, T. Srinivas

  • Donor-Derived Cell-Free DNA Levels During Early Rejection after Kidney Transplant May Be Impacted by Type of Induction Agent Received

    M. Gillespie, K. Lim, A. Vo, E. Huang, N. Ammerman, A. Peng, R. Najjar, S. Sethi, S. Jordan

  • Donor-Derived Cell-Free DNA May Not Discriminate Rejection in Kidney Transplant Recipients with a Prior Allograft in Place

    A. Vo, M. Gillespie, S. C. Jordan, A. Peng, R. Najjar, S. Sethi, K. Lim, N. Ammerman, E. Huang

  • Donor-Derived DCREG Infusion Prolongs Kidney Allograft Survival in Rhesus Monkeys Treated with Co-Stimulation Blockade and Calcineurin Inhibition

    Y. Wang, S. Kazuki, L. Lu, A. Zahorchak, H. Dai, A. Ganoza, M. Wijkstrom, A. Humar, M. Ezzelarab, A. Thomson

  • Donor-Derived Gram-Negative Infections in Solid Organ Transplant Recipients: OPTN DTAC Experience, 2012-2018

    S. Pouch1, B. Plucinski2, R. La Hoz1, A. Agarwal1, S. Aslam1, L. Danziger-Isakov1, S. Ho1, D. Levine1, M. Malinis1, M. Rana1, R. Razonable1, L. Strasfeld1, M. Michaels1

  • Donor-Recipient Genetic Relationship and Outcomes of Living Donor Liver Transplantation (LDLT): Does it Really Matter?

    A. M. Elsabbagh1, A. Mohamed1, E. M. Elsabbagh2, A. Al-Kurd1, T. Ivanics1, E. Ulrich1, T. Kitajima1, M. Rizzari1, K. Collins1, A. Yoshida1, M. Abouljoud1, S. Nagai1

  • Donor-Specific Antibody Test as a Screening Tool for Stable Long-Term Kidney Transplant Recipients

    M. Mohamed1, L. Hidalgo2, S. Parajuli1, N. Garg1, F. Aziz1, K. Swanson1, E. Jochaim1, D. Mandelbrot1, A. Djamali1, B. Astor1

  • Donor-Specific B Cell Frequency Assessed by a Novel Multiplex Bead-Based Assay Predicts Graft Failure in Kidney Transplant Recipients

    Z. Ilyas, A. Akl, D. Pinelli, L. Gallon, A. R. Tambur, M. Ansari

  • Dose Reduction of Anti-Thymocyte Globulin for Kidney Transplant Induction: Possible Cost Savings?

    M. Chaung, E. Hollinger, M. Brokhof, N. Alvey, L. Lineberger, N. Kenyon

  • Dosing and Outcomes of Conversion to Extended-Release Tacrolimus in Heart and Lung Transplant Recipients

    C. Doligalski1, K. Walter1, P. Chang2, L. J. Lobo2

  • Double or Nothing: Reducing Organ Discards by Preemptive Dualization of ‘at Risk’ Single Kidney Offers

    S. K. Patel1, S. Chang2, R. Plews1, R. Sussman3, D. Disante3, D. Schuster1, P. Nguyen1, R. Lopez-Soler4, D. Conti1

  • Dual and Opposite Costimulatory Targeting with a Novel Hybrid Protein Effectively Prevents Renal Warm Ischemia Reperfusion Injury in a Rat Bilateral Kidney Model

    J. Guiteras1, L. De Ramon1, E. Crespo1, N. Bolaños1, P. Fontova1, M. Jarque1, A. Torija1, O. Bestard2, J. Grinyó2, J. Torras2

  • Dual Donor-Recipient Intervention with Recombinant Human C1 Inhibitor Prevents Delayed Graft Function and Reduces Antibody-Mediated Rejection after Kidney Transplantation in Non-Human Primates

    C. Blanton1, J. Reyes1, M. Eerhart1, P. Chlebeck1, M. Springer1, Y. Ponstein2, E. vanAmersfoort2, J. Torrealba3, Y. Yankol1, A. D’Alessandro1, L. Fernandez1

  • Dual Kidney Transplantation Offers a Safe and Effective Way to Use Kidneys from Deceased Donors Older Than 70 Years

    K. Lee, J. Park, S. Cha, M. Kim

  • Duration of Pre-Transplant Abstinence Does Not Predict Severe Relapses of Alcohol Abuse in High-Risk Alcoholic Liver Transplant Recipients

    W. H. Kitchens

Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences